MétaCan
Menu
← Back to cohort
Record W4387080471 · doi:10.21203/rs.3.rs-3283799/v1

SARS-CoV-2 Vaccine Non-response among Hematopoietic Stem Cell Transplant Patients: A Systematic Review and Meta-analysis

2023· review· en· W4387080471 on OpenAlexaboutno aff
Afoke Kokogho, Trevor A. Crowell, Paul Bain, Sudaba Popal, Muneerah M Aleissa, Jun Bai Park Chang, Deema Aleissa, Agho Osamade, Lewis A. Novack, August Heithoff, Lindsey R. Baden, Amy C Sherman, Stephen R. Walsh

Bibliographic record

VenueResearch Square · 2023
Typereview
Languageen
FieldMedicine
TopicSARS-CoV-2 and COVID-19 Research
Canadian institutionsnot available
Fundersnot available
KeywordsMedicineMeta-analysisInternal medicineObservational studyConfidence intervalVaccinationHematopoietic stem cell transplantationSeroconversionAdverse effectSubgroup analysisImmunologyTransplantationAntibody

Abstract

fetched live from OpenAlex

Abstract Background Hematopoietic stem cell transplant (HSCT) recipients are uniquely vulnerable to adverse outcomes of SARS-CoV-2 infection. Small, mostly observational studies suggest that some HSCT recipients may not generate protective antibody responses following SARS-CoV-2 vaccination. We conducted a meta-analysis to estimate the prevalence and identify predictors of vaccine non-response. Methods A comprehensive search of electronic databases, including MEDLINE (Ovid), Embase (Elsevier), Web of Science Core Collection (Clarivate), the Cochrane Central Register of Controlled Trials (Wiley), and the Cochrane COVID-19 Study Register was conducted on January 20, 2023. We defined a non-response as not achieving a seroconversion (positive anti-S IgG titer) after receiving at least two vaccine doses, indicated by study-specific assay cut-off value. Only studies assessing COVID-19 vaccine induced antibody (anti-S IgG) responses in adult (≥ 18 years) HSCT recipients were included. With 95% confidence intervals (CI) across all studies, a random-effects model was used to combine the pooled effect sizes. Quality and risk of bias assessment were determined using the Newcastle-Ottawa scale and ROBINS-I tool, respectively. Results Out of 903 unique articles identified and 439 screened, 45 were included in this analysis comprising 4568 participants. Pooled absent sero-conversion was 20% (95% CI: 17% − 24%) with significant heterogeneity (I2 = 95.10%) among included studies (1 clinical trial, 1 cross-sectional study, 1 case-control study, and 42 observational cohort studies). Subgroup analyses showed no difference between autologous [0.21 (95%CI 0.12–0.31)] and allogeneic [0.20 (95%CI 0.17–0.24)] transplant recipients. Identified predictors of non-response included time interval between transplantation and vaccination (< 12 months), concurrent anti-CD20 therapy, and specific treatments (high-dose glucocorticosteroid, calcineurin inhibitor, and anti-thymocyte globulin) for graft versus host disease. No publication bias was observed but the Galbraith’s plot asymmetry showed evidence of small-study effects. Conclusion Our findings emphasize the significant prevalence of non-responsiveness to SARS-CoV-2 vaccination in HSCT recipients and underscore need for close monitoring and aggressive risk factor management in this immunocompromised population.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.011
metaresearch head score (Gemma)0.030
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Meta-analysis · Consensus signal: none
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.023
Threshold uncertainty score0.059

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0110.030
Meta-epidemiology (narrow)0.0030.002
Meta-epidemiology (broad)0.0230.040
Bibliometrics0.0080.009
Science and technology studies0.0010.001
Scholarly communication0.0040.002
Open science0.0020.002
Research integrity0.0020.002
Insufficient payload (model declined to judge)0.0040.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.184
GPT teacher head0.454
Teacher spread0.270 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designMeta-analysis
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2023
Admission routes1
Has abstractyes

Explore more

Same venueResearch Square→Same topicSARS-CoV-2 and COVID-19 Research→French-language works237,207→